David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$686M |
| 2 |
Walt Disney
DIS
|
+$555M |
| 3 |
Palantir
PLTR
|
+$522M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$493M |
| 5 |
TSMC
TSM
|
+$464M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$981M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$951M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$596M |
| 4 |
Eli Lilly
LLY
|
+$555M |
| 5 |
Arthur J. Gallagher & Co
AJG
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.18% |
| 2 | Healthcare | 9.91% |
| 3 | Consumer Discretionary | 9.25% |
| 4 | Financials | 6.45% |
| 5 | Industrials | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
PUT
Synopsys
SNPS
$75.5B
| $9.01M | 0.01% |
21,000
-4,200
| -17% | -$2.04M |
|
1377
Krystal Biotech
KRYS
$10.5B
| $9M | 0.01% |
49,892
+42,465
| +572% | +$7.14M |
|
1378
ICU Medical
ICUI
$4.56B
| $8.97M | 0.01% |
+64,619
| New | +$10M |
|
1379
Affiliated Managers Group
AMG
$9.45B
| $8.95M | 0.01% |
53,243
-16,879
| -24% | -$2.94M |
|
|
JACS
1380
Jackson Acquisition Co II
JACS
$318M
| $8.94M | 0.01% |
+888,000
| New | +$8.9M |
|
1381
PUT
Owens Corning
OC
$11.6B
| $8.93M | 0.01% |
+62,500
| New | +$10.3M |
|
1382
Methode Electronics
MEI
$570M
| $8.91M | 0.01% |
1,395,994
-61,462
| -4% | -$606K |
|
|
HVII
1383
Hennessy Capital Investment Corp VII
HVII
$204M
| $8.89M | 0.01% |
+899,662
| New | +$8.85M |
|
1384
ATN International
ATNI
$473M
| $8.88M | 0.01% |
437,435
+4,732
| +1% | +$84.8K |
|
1385
Birkenstock
BIRK
$5.83B
| $8.87M | 0.01% |
193,409
-37,561
| -16% | -$1.98M |
|
|
ALDF
1386
Aldel Financial II Inc
ALDF
$322M
| $8.86M | 0.01% |
877,644
+677,715
| +339% | +$6.79M |
|
|
NAGE
1387
Niagen Bioscience
NAGE
$259M
| $8.86M | 0.01% |
1,283,790
+272,500
| +27% | +$1.71M |
|
1388
CALL
JD.com
JD
$39.7B
| $8.84M | 0.01% |
215,100
-750,800
| -78% | -$30.1M |
|
1389
Kiniksa Pharmaceuticals
KNSA
$6.26B
| $8.83M | 0.01% |
397,745
+77,738
| +24% | +$1.6M |
|
1390
Compass
COMP
$9.06B
| $8.83M | 0.01% |
1,011,412
-657,438
| -39% | -$5.21M |
|
1391
Steven Madden
SHOO
$3.33B
| $8.8M | 0.01% |
330,462
+294,949
| +831% | +$10.4M |
|
1392
CALL
C3.ai
AI
$1.52B
| $8.79M | 0.01% |
417,700
-670,900
| -62% | -$19M |
|
1393
PUT
Johnson & Johnson
JNJ
$658B
| $8.79M | 0.01% |
53,000
-111,800
| -68% | -$17.5M |
|
|
OACC
1394
Oaktree Acquisition Corp III Life Sciences
OACC
$265M
| $8.79M | 0.01% |
+861,625
| New | +$8.65M |
|
1395
PUT
AT&T
T
$177B
| $8.77M | 0.01% |
310,000
-489,100
| -61% | -$12.3M |
|
|
RANG
1396
Range Capital Acquisition Corp
RANG
$72.3M
| $8.74M | 0.01% |
+870,000
| New | +$8.68M |
|
1397
Autoliv
ALV
$9.08B
| $8.74M | 0.01% |
98,766
+69,787
| +241% | +$6.65M |
|
1398
Enerpac Tool Group
EPAC
$1.91B
| $8.71M | 0.01% |
194,248
-26,229
| -12% | -$1.16M |
|
1399
Excelerate Energy
EE
$1.24B
| $8.71M | 0.01% |
303,747
-131,546
| -30% | -$3.93M |
|
1400
Albany International
AIN
$1.65B
| $8.7M | 0.01% |
126,028
+50,506
| +67% | +$3.93M |
|
Similar funds
David Shaw's Q1 2025 Portfolio in Review
As of Q1 2025, David Shaw held 4,902 positions worth $112B, down 18% from $136B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $21.6B in Q1 2025, closing 704 positions and reducing 1,734 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $951M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in KKR & Co 6.25% Series D Preferred Stock worth $88.2M.
- David Shaw's largest Q1 2025 buy was KKR & Co 6.25% Series D Preferred Stock: 1,800,000 shares worth $88.2M.
- David Shaw added most to GE Vernova in Q1 2025, an estimated $686M increase.
- David Shaw's biggest Q1 2025 reduction was Boeing, cutting an estimated $981M.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $951M.
- David Shaw's ten largest holdings make up 11% of its $112B portfolio in Q1 2025.
- David Shaw opened 569 new positions and closed 704 in Q1 2025.
- David Shaw's portfolio value fell 18% quarter-over-quarter to $112B.
Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.